Skip to main content
Public and Media relations

Press Centre

EANM / Public and Media relations / Press Centre

Press Centre

Get in touch with our team: If you’re a journalist, medical writer or reporter looking for a background briefing, commentary, or an interview with a nuclear medicine specialist, please contact press@eanm.org.

Press coverage at the EANM Annual Congress: Press representatives can receive free registration to our Annual Congress by submitting a valid press pass. More information will be available closer to the congress.

Media distribution list & contact

Are you interested in receiving news about EANM and nuclear medicine? We will be happy to add you to our list of registered journalists and provide you with relevant press releases.

If you would like to be added, please write us at press@eanm.org.

Contact us

EANM figures and facts
Overview:

EANM is the largest non-profit medical organisation dedicated to nuclear medicine in Europe. Since its establishment in 1985, EANM has consistently aimed to provide an interactive platform for the sharing and discussion of cutting-edge developments in the field by bringing together nuclear medicine physicians, medical physicists, radiochemists, pharmacists, technologists, and experts from related areas.

Events:

The next EANM’27 congress will be held in Hamburg (Germany) on October 9-13, 2027. In addition, EANM organises every year other scientific events to foster knowledge exchange. 

EANM in numbers:
  • Over 3,500 members across the EANM community
  • 40 national member societies based in Europe
  • 9,821 participants, 187 exhibitors, 2,497 accepted abstracts and 14 satellite symposia at the EANM’26 Annual Congress in Vienna, Austria
  • 2 journals: The EANM Journal and EANM Innovation
  • 1 educational school: The European School of Multimodality Imaging & Therapy (ESMIT), welcoming over 2,800 attendees annually, with 11,170 platform users and more than 20 educational events per year
  • 1 research entity dedicated to harmonisation, EANM Forschungs GmbH (EARL), offering accreditation programmes since 2010

Most recent press releases

New PET imaging approach detects almost all lesions in common form of kidney cancer

Vienna, Austria, October 20, 2026

A new PET imaging approach detected 97.9% of lesions in clear cell renal cell carcinoma (ccRCC), potentially giving clinicians a more complete picture of the location and extent of a patient’s disease.

Read now

 

Next-generation total-body PET scanner can produce diagnostic-quality images in as little as one minute 

Vienna, Austria, October 18, 2026

A next-generation total-body PET/CT scanner can produce diagnostic-quality images in as little as one minute of scanning. Even its fastest images were rated more highly on average than those from a standard PET/CT scanner.

Read now

Amyloid and tau PET as key technologies for modern Alzheimer’s treatment 

Vienna, Austria, October 14, 2026

For the treatment of Alzheimer’s disease with the first causally effective drugs, lecanemab and donanemab, amyloid PET scans are required to determine when to discontinue therapy. TAU PET provides essential prognostic information on whether a patient is suitable for this modern Alzheimer’s and what their chance of success are when taking the drugs.

Read now